English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Monday, October 21, 2024
康哲藥業入選2024年度「中國醫藥上市公司ESG競爭力」系列榜單
Friday, October 18, 2024
康哲藥業:蘆可替尼乳膏(白癜風)大灣區首批處方落地
Tuesday, September 24, 2024
康哲藥業:磷酸蘆可替尼乳膏(白癜風)中國上市許可申請已獲受理
Monday, April 1, 2024
CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia
Thursday, August 13, 2020
康哲药业控股有限公司2020年中期业绩公布
康哲藥業控股有限公司2020年中期業績公佈
Monday, March 7, 2011
康哲药业再度入选「2011福布斯中国最佳潜力企业」
康哲藥業再度入選「2011福布斯中國最佳潛力企業」
China Medical System Accredited by 'China's Top 100 Potential Enterprises' by Forbes China for Two Consecutive Years
Friday, January 28, 2011
康哲药业原发性肝癌药CMS024可望提前三年于2013年推出市场

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575